TubeSolar AG
XETRA:9TS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TubeSolar AG
XETRA:9TS
|
DE |
|
A
|
Arrivent Biopharma Inc
NASDAQ:AVBP
|
US |
|
Sterling Group Holdings Ltd
HKEX:1825
|
HK |
|
G
|
Global Blood Therapeutics Inc
F:G5B
|
US |
|
Magnolia Oil & Gas Corp
NYSE:MGY
|
US |
|
Polaris Infrastructure Inc
TSX:PIF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 9TS's stock price target?
Not Available
9TS doesn't have any price targets made by Wall Street professionals.
What is TubeSolar AG's Revenue forecast?
Projected CAGR
36%
For the last 1 year the compound annual growth rate for TubeSolar AG's revenue is 176%. The projected CAGR for the next 2 years is 36%.